Approval · Notice of Compliance 25234 · 2021
CEQUA: Notice of Compliance 25234
Issued February 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25234
- Date
- February 16, 2021
- Company
- Sun Pharma Global Fze
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEQUA | 02512629 | Marketed |
Medicinal ingredients
- CYCLOSPORINE 0.09 PER